Related Experiment Video
Updated: Jun 28, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Attenuating effects of heat-processed Panax ginseng (Red and Black) on methamphetamine-induced behaviors via
Chul Kyu Lee1, Sun Mi Gu1, Bongjun Kim1
1College of Pharmacy, Chungbuk National University, 194-31 Osongsaengmyeong 1-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28160, Republic of Korea.
Abstract:
Methamphetamine (METH) is one of the most widely used psychostimulants associated with substance use disorders. Korean red ginseng extract (RGE), produced by the single steaming process of Panax ginseng, has been reported to inhibit drug-induced reward behavior in several animal models. However, research on the effects of Korean black ginseng extract (BGE), produced by repeated steaming cycles (typically at least three times) of Panax ginseng, on methamphetamine-induced conditioned place preference (CPP) in mice remains limited. In this study, male C57BL/6 N mice were treated according to the same schedule used for CPP, pretreated with RGE or BGE, followed by behavioral and biochemical analyses, including conditioned place preference (CPP), Western blotting (WB), immunohistochemistry (IHC), and high-performance liquid chromatography (HPLC) in the striatum and nucleus accumbens. Our results demonstrate that pretreatment with RGE and BGE inhibited METH-induced CPP. We also found that pretreatment with RGE and BGE reversed METH-induced changes in dopamine-related protein expression, neurotransmission, and dopamine levels, suggesting that ginseng extracts may modulate dopaminergic signaling associated with drug reward.
Related Concept Videos
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Drugs Affecting Neurotransmitter Synthesis
Drugs Affecting Neurotransmitter Release or Uptake
